A pharmaceutical cocrystal of apigenin with piperazine: Preparation, structural characterization, and dissolution performance

被引:6
作者
Zhang, Jie [1 ]
Shen, Rui [1 ]
Zhang, Xu [1 ]
Li, Gen [1 ]
Wang, Xi [1 ]
机构
[1] Tianjin Univ Tradit Chinese Med, Sch Chinese Mat Med, Tianjin 300193, Peoples R China
关键词
Apigenin; Piperazine; Pharmaceutical cocrystal; Single crystal X-ray diffraction; Hirshfeld surfaces; Solubility; SOLID-STATE CHARACTERIZATION; FLAVONOIDS; QUERCETIN; BIOAVAILABILITY; SOLUBILITY; MYRICETIN; STRATEGY; RATIO; SALT;
D O I
10.1016/j.molstruc.2023.137027
中图分类号
O64 [物理化学(理论化学)、化学物理学];
学科分类号
070304 ; 081704 ;
摘要
As a natural flavonoid, apigenin (APG) has garnered considerable attention for its broad pharmacological properties. Unfortunately, the extremely poor aqueous solubility greatly restricts its clinical efficacy. Cocrystallization has been taken as an important approach to modulate physicochemical properties of parent drug. In this paper, piperazine (PIP) has been selected to assembly with APG and APG-PIP cocrystal has been successfully fabricated and characterized by single crystal X-ray diffraction and various analytical methods. Single-crystal X-ray diffraction analysis indicates APG-PIP crystallizes in the P21/c space group of monoclinic system and comprises neutral APG and PIP with the ratio of 1:1. APG and PIP are linked via O-H & sdot;& sdot;& sdot;N/N-H & sdot;& sdot;& sdot;O hydrogen bonds with a resulting 2D fes network. The 2D networks are further extended via pi & sdot;& sdot;& sdot;pi stacking interactions to afford its 3D architecture. The APG illustrates highly enhanced solubility and dissolving rate in APG-PIP cocrystal comparing with parent APG. It is notable that APG-PIP presents different equilibrium concentrations of APG along with insoluble residue when different dosages of APG-PIP are introduced. We speculate that APG and PIP may not be released equally within APG-PIP in aqueous medium due to their neutral nature and huge difference in solubility, and the existence of PIP can facilitate the dissolving of APG. This speculation has been further confirmed by investigation of relationship between equilibrium concentrations of APG and dosage of APG-PIP as well as powder dissolution experiment. The equilibrium concentrations are 0.118, 0.382, 0.556, 0.767, and 0.904 mg/mL when 5, 10, 15, 20, and 25 mg APG-PIP was put into 5 mL H2O and reveals good linear relation. The "spring and parachute" phenomenon and final similar solubility with parent APG in powder dissolution profile can be ascribed to the synergetic effect of metastable supersaturation and decreased PIP concentration due to withdrawing-replenishing operation.
引用
收藏
页数:7
相关论文
共 31 条
[1]   Health functionality of apigenin: A review [J].
Ali, Fahad ;
Rahul ;
Naz, Falaq ;
Jyoti, Smita ;
Siddique, Yasir Hasan .
INTERNATIONAL JOURNAL OF FOOD PROPERTIES, 2017, 20 (06) :1197-1238
[2]   Effects of C-glycosylation on anti-diabetic, anti-Alzheimer's disease and anti-inflammatory potential of apigenin [J].
Choi, Jae Sue ;
Islam, Md. Nurul ;
Ali, Md. Yousof ;
Kim, Eon Ji ;
Kim, Young Myeong ;
Jung, Hyun Ah .
FOOD AND CHEMICAL TOXICOLOGY, 2014, 64 :27-33
[3]   GRAPH-SET ANALYSIS OF HYDROGEN-BOND PATTERNS IN ORGANIC-CRYSTALS [J].
ETTER, MC ;
MACDONALD, JC ;
BERNSTEIN, J .
ACTA CRYSTALLOGRAPHICA SECTION B-STRUCTURAL SCIENCE CRYSTAL ENGINEERING AND MATERIALS, 1990, 46 :256-262
[4]   Pharmaceutical cocrystals: A review of preparations, physicochemical properties and applications [J].
Guo, Minshan ;
Sun, Xiaojie ;
Chen, Jiahui ;
Cai, Ting .
ACTA PHARMACEUTICA SINICA B, 2021, 11 (08) :2537-2564
[5]   Zwitterionic Cocrystals of Flavonoids and Proline: Solid-State Characterization, Pharmaceutical Properties, and Pharmacokinetic Performance [J].
He, Hongyan ;
Huang, Ying ;
Zhang, Qi ;
Wang, Jian-Rong ;
Mei, Xuefeng .
CRYSTAL GROWTH & DESIGN, 2016, 16 (04) :2348-2356
[6]   A Novel Strategy for Pharmaceutical Cocrystal Generation Without Knowledge of Stoichiometric Ratio: Myricetin Cocrystals and a Ternary Phase Diagram [J].
Hong, Chao ;
Xie, Yan ;
Yao, Yashu ;
Li, Guowen ;
Yuan, Xiurong ;
Shen, Hongyi .
PHARMACEUTICAL RESEARCH, 2015, 32 (01) :47-60
[7]   Preparation of inclusion complex of apigenin-hydroxypropyl-β-cyclodextrin by using supercritical antisolvent process for dissolution and bioavailability enhancement [J].
Huang, Yannian ;
Zu, Yuangang ;
Zhao, Xiuhua ;
Wu, Mingfang ;
Feng, Ziqi ;
Deng, Yiping ;
Zu, Chang ;
Wang, Lingling .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2016, 511 (02) :921-930
[8]   Pharmaceutical cocrystals: from serendipity to design to application [J].
Kavanagh, Oisin N. ;
Croker, Denise M. ;
Walker, Gavin M. ;
Zaworotko, Michael J. .
DRUG DISCOVERY TODAY, 2019, 24 (03) :796-804
[9]   Cocrystals and a Salt of the Bioactive Flavonoid: Naringenin [J].
Khandavilli, U. B. Rao ;
Skorepova, Eliska ;
Sinha, Abhijeet S. ;
Bhogala, Balakrishna R. ;
Maguire, Nuala M. ;
Maguire, Anita R. ;
Lawrence, Simon E. .
CRYSTAL GROWTH & DESIGN, 2018, 18 (08) :4571-4577
[10]   The natural plant flavonoid apigenin is a strong antioxidant that effectively delays peripheral neurodegenerative processes [J].
Kim, Muwoong ;
Jung, Junyang ;
Jeong, Na Young ;
Chung, Hyung-Joo .
ANATOMICAL SCIENCE INTERNATIONAL, 2019, 94 (04) :285-294